Zobrazeno 1 - 10
of 302
pro vyhledávání: '"Kaidarova, D"'
Autor:
Kassymbekova F; Department of Public Health and Social Sciences, Kazakhstan Medical University Higher School of Public Health, Almaty, Kazakhstan., Glushkova N; Department of Epidemiology, Biostatistics and Evidence Based Medicine, Al-Farabi Kazakh National University, Almaty, Kazakhstan. glushkovanatalyae@gmail.com., Dunenova G; Department of Epidemiology, Biostatistics and Evidence Based Medicine, Al-Farabi Kazakh National University, Almaty, Kazakhstan., Kaidarova D; Kazakh Institute of Oncology and Radiology, Almaty, Kazakhstan., Kissimova-Skarbek K; Institute of Public Health, Faculty of Health Sciences, Jagiellonian University Medical College, Krakow, Poland., Wengler A; Department of Epidemiology and Health Monitoring, Robert Koch-Institute, Berlin, Germany., Zhetpisbayeva I; Asfendiyarov Kazakh National Medical University, Almaty, Kazakhstan., Shatkovskaya O; Kazakh Institute of Oncology and Radiology, Almaty, Kazakhstan., Andreyeva O; Center of Nuclear Medicine and Oncology, Semey State Medical University, Semey, Kazakhstan., Davletov K; Asfendiyarov Kazakh National Medical University, Almaty, Kazakhstan., Auyezova A; Rector Office, Kazakhstan Medical University Higher School of Public Health, Almaty, Kazakhstan., Rommel A; Department of Epidemiology and Health Monitoring, Robert Koch-Institute, Berlin, Germany.
Publikováno v:
Scientific reports [Sci Rep] 2024 Sep 04; Vol. 14 (1), pp. 20536. Date of Electronic Publication: 2024 Sep 04.
Autor:
Latino, N.J., Galotti, M., Cherny, N.I., de Vries, E.G.E., Douillard, J.-Y., Kaidarova, D., Ilbawi, A.
Publikováno v:
In ESMO Open February 2022 7(1)
Autor:
Kadyrbayeva R; Chemotherapy Center, Kazakh Institute of Oncology and Radiology, Almaty, Republic of Kazakhstan - kadyrbayevarabiga48@hotmail.com.; Department of Oncology, Asfendiyarov Kazakh National Medical University, Almaty, Republic of Kazakhstan - kadyrbayevarabiga48@hotmail.com., Kaidarova D; Department of Oncology, Asfendiyarov Kazakh National Medical University, Almaty, Republic of Kazakhstan.; Kazakh Institute of Oncology and Radiology, Almaty, Republic of Kazakhstan., Shatkovskaya O; Kazakh Institute of Oncology and Radiology, Almaty, Republic of Kazakhstan., Goncharova T; Kazakh Institute of Oncology and Radiology, Almaty, Republic of Kazakhstan., Orazgalieva M; Center for Molecular Genetic Research, Kazakh Institute of Oncology and Radiology, Almaty, Republic of Kazakhstan., Ossikbayeva S; Center for Molecular Genetic Research, Kazakh Institute of Oncology and Radiology, Almaty, Republic of Kazakhstan.
Publikováno v:
Panminerva medica [Panminerva Med] 2024 Sep 27. Date of Electronic Publication: 2024 Sep 27.
Autor:
Dunenova G; Department of Epidemiology, Biostatistics and Evidence-Based Medicine, Al-Farabi Kazakh National University, Almaty 050040, Kazakhstan., Kalmataeva Z; Rector Office, Asfendiyarov Kazakh National Medical University, Almaty 050000, Kazakhstan., Kaidarova D; Kazakh Research Institute of Oncology and Radiology, Almaty 050022, Kazakhstan., Dauletbaev N; Department of Internal, Respiratory and Critical Care Medicine, Philipps University of Marburg, 35037 Marburg, Germany.; Department of Pediatrics, Faculty of Medicine and Health Sciences, McGill University, Montreal, QC H4A 3J1, Canada.; Faculty of Medicine and Health Care, Al-Farabi Kazakh National University, Almaty 050040, Kazakhstan., Semenova Y; School of Medicine, Nazarbayev University, Astana 010000, Kazakhstan., Mansurova M; Department of Artificial Intelligence and Big Data, Al-Farabi Kazakh National University, Almaty 050040, Kazakhstan., Grjibovski A; Central Scientific Research Laboratory, Northern State Medical University, Arkhangelsk 163000, Russia.; Department of Epidemiology and Modern Vaccination Technologies, I.M. Sechenov First Moscow State Medical University, Moscow 105064, Russia.; Department of Biology, Ecology and Biotechnology, Northern (Arctic) Federal University, Arkhangelsk 163000, Russia.; Department of Health Policy and Management, Al-Farabi Kazakh National University, Almaty 050040, Kazakhstan., Kassymbekova F; Department of Public Health and Social Sciences, Kazakhstan Medical University 'KSPH', Almaty 050060, Kazakhstan., Sarsembayev A; School of Digital Technologies, Almaty Management University, Almaty 050060, Kazakhstan.; Health Research Institute, Al-Farabi Kazakh National University, Almaty 050040, Kazakhstan., Semenov D; Computer Science and Engineering Program, Astana IT University, Astana 020000, Kazakhstan., Glushkova N; Department of Epidemiology, Biostatistics and Evidence-Based Medicine, Al-Farabi Kazakh National University, Almaty 050040, Kazakhstan.; Health Research Institute, Al-Farabi Kazakh National University, Almaty 050040, Kazakhstan.
Publikováno v:
Cancers [Cancers (Basel)] 2024 Aug 03; Vol. 16 (15). Date of Electronic Publication: 2024 Aug 03.
Autor:
Reid F; World Ovarian Cancer Coalition, Toronto, Ontario, Canada., Adams T; Department of Obstetrics and Gynaecology, Groote Schuur Hospital, Cape Town, South Africa.; South African Medical Research Centre Gynaecological Cancer Research Centre (SA MRC UCT GCRC), Cape Town, South Africa., Adel RS; World Ovarian Cancer Coalition, Toronto, Ontario, Canada.; CancerBD, Dhaka, Bangladesh., Andrade CE; Department of Gynecologic Oncology, Barretos Cancer Hospital, Barretos, Brazil., Bajwa A; World Ovarian Cancer Coalition, Toronto, Ontario, Canada., Bambury IG; University of the West Indies, Kingston, Jamaica., Benhima N; Department of Medical Oncology, Mohammed VI University Hospital, Marrakech, Morocco., Bolatbekova R; Kazakh Institute of Oncology and Radiology, Almaty, Kazakhstan., Leon DC; Instituto Nacional de Cancerología, Ciudad de México, México., Charlton P; World Ovarian Cancer Coalition, Toronto, Ontario, Canada., Chirinos CC; Instituto Regional de Enfermedades Neoplásicas, Arequipa, Perú., Cohen R; World Ovarian Cancer Coalition, Toronto, Ontario, Canada.; Sandy Rollman Ovarian Cancer Foundation, Wynnewood, Pennsylvania, United States of America., Eiken M; International Gynecologic Cancer Society, Chicago, Illinois, United States of America., Estrada EE; Hospital General San Juan de Dios, Guatemala City, Guatemala., Kaidarova D; Kazakh Institute of Oncology and Radiology, Almaty, Kazakhstan., Lau I; Ovarian Cancer Malaysia, Kuala Lumpur, Malaysia., MacKay C; World Ovarian Cancer Coalition, Toronto, Ontario, Canada., Makondi PT; National Cancer Center, Kamuzu Central Hospital, Kamuzu, Malawi., Mukhopadhyay A; Kolkata Gynaecological Oncology Trials and Translational Research Group, Kolkata, India., Mustapha A; Ahmadu Bello University Teaching Hospital, Zaria, Kaduna State, Nigeria., Noll F; Sanatorio Allende, Cordoba, Argentina., Origa M; Uganda Cancer Institute, Kampala, Uganda., Pariyar J; Civil Service Hospital of Nepal, Kathmandu, Nepal., Pervin S; National Institute of Cancer Research & Hospital, Dhaka, Bangladesh., Phan NTH; Danang Oncology Hospital, Danang, Vietnam., Refky B; Mansoura University Oncology Center, Mansoura, Egypt., Shaffi AF; Moi University/Moi Teaching and Referral Hospital, Eldoret, Kenya., Strömsholm EM; Gynecological Cancer Patients in Finland, Helsinki, Finland., Woo YL; Department of Obstetrics and Gynaecology, University Malaya Medical Centre, Kuala Lumpur, Malaysia., Yoon SY; Department of Obstetrics and Gynaecology, University Malaya Medical Centre, Kuala Lumpur, Malaysia., Zakirova N; Republican Specialized Scientific and Practical Medical Center of Oncology and Radiology of the Ministry of Health of the Republic of Uzbekistan, Tashkent, Uzbekistan., Chidebe RCW; World Ovarian Cancer Coalition, Toronto, Ontario, Canada.; Project PINK BLUE, Abuja, Nigeria.; Department of Sociology & Gerontology, Miami University, Oxford, Ohio, United States of America., Funston G; Wolfson Institute of Population Health, Queen Mary University of London, London, United Kingdom., Soerjomataram I; Cancer Surveillance Branch, International Agency for Research on Cancer, Lyon, France.
Publikováno v:
PloS one [PLoS One] 2024 May 29; Vol. 19 (5), pp. e0298154. Date of Electronic Publication: 2024 May 29 (Print Publication: 2024).
Autor:
Arynov A; Department of Anesthesiology and Intensive Care, Kazakh Institute of Oncology and Radiology, Abay av. 91, Almaty, Kazakhstan. ardak6183307@gmail.com., Kaidarova D; Kazakh Institute of Oncology and Radiology, Abay av. 91, Almaty, Kazakhstan., Kabon B; Department of Anaesthesia, General Intensive Medicine and Pain Medicine Medical, University of Vienna, Spitalgasse 23, 1090, Vienna, Austria.
Publikováno v:
BMC anesthesiology [BMC Anesthesiol] 2024 Feb 23; Vol. 24 (1), pp. 71. Date of Electronic Publication: 2024 Feb 23.
Autor:
Satanova A; Oncogynecological Center, Kazakh Institute of Oncology and Radiology, Almaty, Republic of Kazakhstan., Bolatbekova R; Oncogynecological Department, Kazakh Institute of Oncology and Radiology, Almaty, Republic of Kazakhstan., Kukubassov Y; Oncogynecological Center, Kazakh Institute of Oncology and Radiology, Almaty, Republic of Kazakhstan., Ossikbayeva S; Centre for Molecular Genetic Research, Kazakh Institute of Oncology and Radiology, Almaty, Republic of Kazakhstan., Kaidarova D; Kazakh Institute of Oncology and Radiology, Almaty, Republic of Kazakhstan.
Publikováno v:
Asian Pacific journal of cancer prevention : APJCP [Asian Pac J Cancer Prev] 2024 Feb 01; Vol. 25 (2), pp. 681-688. Date of Electronic Publication: 2024 Feb 01.
Autor:
Berasaluce Gómez A., Martín-Calvo N., Boria F., Manzour N., Chacón E., Bizzarri N., Chiva L., Martinez A., Quesada A., Kucukmetin A., Vázquez A., Mandic A., Casajuana A., Kavallaris A., Fagotti A., Perrone A., Ferrero A., Lekuona A., Uppin A., Stepanyan A., Chiofalo B., Morillas B., Tauste C., Andrade C., Mom C., Brucker C., Sarac C. P., Vázquez-Vicente D., Cibula D., Querleu D., Erasun D., Kaidarova D., Tsolakidis D., Haidopoulos D., Golub D., Bonci E. A., Aksahin E., Gonçalves E., Moratalla E., Karaman E., Myriokefalitaki E., Ghezzi F., Narducci F., Roldan F., Raspagliesi F., Goffin F., Grandjean F., Guyon F., Demirkiran F., Fiol G., Chakalova G., Mancebo G., Vorgias G., Gebauer G., Meili G., Hernandez-Cortes G., Bogani G., Cordeiro G., Vujić G., Mendinhos G., Trum H., Bonsang-Kitzis H., Haller H., Vergote I., Zapardiel I., Aluloski I., Berlev I., Pete I., Kalogiannidis I., Kotsopoulos I., Yezhova I., Díez J., Feron J. G., Scharf J. P., Beltman J., Haesen J., Ponce J., Cea J., Mínguez J. Á., García J., Arévalo-Serrano J., Gilabert J., Alcazar J. L., Kukk K., Galaal K., Cárdenas L., Pirtea L., Mereu L., Anchora L. P., Dostalek L., Klasa L., PakižImre M., Undurraga M., Jedryka M., Bernardino M., Alonso-Espias M., Martín-Salamanca M. B., Cuadra M., Tavares M., Malzoni M., Fruscio R.
Background: The SUCCOR cohort was developed to analyse the overall and disease-free survival at 5 years in women with FIGO 2009 stage IB1 cervical cancer. The aim of this study was to compare the use of adjuvant therapy in these women, depending on t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______1299::b9001d7219b286de805abc3d9701dca7
https://hdl.handle.net/10281/419539
https://hdl.handle.net/10281/419539
Autor:
Skvortsova L; Laboratory of Molecular Genetics, Institute of Genetics and Physiology, Almaty 050060, Kazakhstan., Abdikerim S; Laboratory of Molecular Genetics, Institute of Genetics and Physiology, Almaty 050060, Kazakhstan.; Department of Molecular Biology and Genetics, Al-Farabi Kazakh National University, Almaty 050040, Kazakhstan., Yergali K; Laboratory of Molecular Genetics, Institute of Genetics and Physiology, Almaty 050060, Kazakhstan., Mit N; Laboratory of Molecular Genetics, Institute of Genetics and Physiology, Almaty 050060, Kazakhstan., Perfilyeva A; Laboratory of Molecular Genetics, Institute of Genetics and Physiology, Almaty 050060, Kazakhstan., Omarbayeva N; Breast Cancer Department, Kazakh Institute of Oncology and Radiology, Almaty 050060, Kazakhstan.; Oncology Department, Asfendiyarov Kazakh National Medical University, Almaty 050012, Kazakhstan., Zhunussova A; Laboratory of Molecular Genetics, Institute of Genetics and Physiology, Almaty 050060, Kazakhstan., Kachiyeva Z; Research Institute of Applied and Fundamental Medicine, Asfendiyarov Kazakh National Medical University, Almaty 050012, Kazakhstan., Sadykova T; Breast Cancer Department, Kazakh Institute of Oncology and Radiology, Almaty 050060, Kazakhstan.; Oncology Department, Asfendiyarov Kazakh National Medical University, Almaty 050012, Kazakhstan., Bekmanov B; Laboratory of Molecular Genetics, Institute of Genetics and Physiology, Almaty 050060, Kazakhstan.; Department of Molecular Biology and Genetics, Al-Farabi Kazakh National University, Almaty 050040, Kazakhstan., Kaidarova D; Breast Cancer Department, Kazakh Institute of Oncology and Radiology, Almaty 050060, Kazakhstan.; Oncology Department, Asfendiyarov Kazakh National Medical University, Almaty 050012, Kazakhstan., Djansugurova L; Laboratory of Molecular Genetics, Institute of Genetics and Physiology, Almaty 050060, Kazakhstan.; Department of Molecular Biology and Genetics, Al-Farabi Kazakh National University, Almaty 050040, Kazakhstan., Zhunussova G; Laboratory of Molecular Genetics, Institute of Genetics and Physiology, Almaty 050060, Kazakhstan.
Publikováno v:
Genes [Genes (Basel)] 2024 Jan 17; Vol. 15 (1). Date of Electronic Publication: 2024 Jan 17.
Autor:
Kaidarova D; Kazakh Institute of Oncology and Radiology of the Ministry of Health of the Republic of Kazakhstan, Almaty, Kazakhstan., Zhavrid E; N.N.Alexandrov National Cancer Center of Belarus, Belarus., Shatkovskaya O; Kazakh Institute of Oncology and Radiology of the Ministry of Health of the Republic of Kazakhstan, Almaty, Kazakhstan., Prokharau A; Minsk Clinical Cancer Center/Department of Oncology, Belarusian State Medical University, Minsk, Belarus., Akhmed N; N.N.Alexandrov National Cancer Center of Belarus, Belarus., Sembayev D; Department of Chemotherapy, Multidisciplinary Medical Center of Akimat of Astana, Astana, Kazakhstan., Rutzhanova Z; Department of Chemotherapy, Multidisciplinary Medical Center of Akimat of Astana, Astana, Kazakhstan., Ivankov A; Independent Researcher, Almaty, Kazakhstan. Electronic address: sash.ivankov@gmail.com.
Publikováno v:
Cancer treatment and research communications [Cancer Treat Res Commun] 2024; Vol. 40, pp. 100817. Date of Electronic Publication: 2024 May 01.